Geocann
Geocann develops clinically investigated phytocannabinoid and terpene formulations and applies lipid-based colloidal delivery technologies to improve absorption and bioavailability. The company provides formulation development, licensed delivery technologies, technical partnerships, analytical testing oversight and global product distribution support for consumer, medical and animal-nutrition markets. Its delivery-platform work is supported by decades of published pharmacokinetic evidence and a history of commercializing delivery-system formulations globally.
Industries
Nr. of Employees
small (1-50)
Products
Soft gel capsules
Oral softgel dosage form containing lipid-based colloidal fills designed to form nanoscale droplets at body temperature to improve dissolution and absorption of lipophilic actives.
Edible formats (gummies, lozenges, chocolates)
Chewable and ingestible formats formulated to provide more rapid and predictable onset using colloidal delivery approaches.
Beverage and powder formats
Water-dispersible powders and ready-to-drink beverage formulations that enable dispersion of lipophilic bioactives into aqueous drinks using micelle/micro-emulsion technologies.
Topical formulations
Dermal formulations optimized for penetration and faster onset of lipophilic actives for localized relief or cosmetic applications.
Standardized ingredient types (oils, distillates, isolates)
Supply of starting materials and standardized ingredient formats (full/broad spectrum oils, water-soluble powders, distillates, isolates) available in conventional or delivery-optimized formulations for manufacturing.
VESIsorb
An exclusively licensed drug delivery technology that dramatically improves the bioavailability and absorption of poorly absorbed ingredients like cannabis oil by utilizing a self-assembling colloidal system.
Soft gel capsules
Oral softgel dosage form containing lipid-based colloidal fills designed to form nanoscale droplets at body temperature to improve dissolution and absorption of lipophilic actives.
Edible formats (gummies, lozenges, chocolates)
Chewable and ingestible formats formulated to provide more rapid and predictable onset using colloidal delivery approaches.
Beverage and powder formats
Water-dispersible powders and ready-to-drink beverage formulations that enable dispersion of lipophilic bioactives into aqueous drinks using micelle/micro-emulsion technologies.
Topical formulations
Dermal formulations optimized for penetration and faster onset of lipophilic actives for localized relief or cosmetic applications.
Standardized ingredient types (oils, distillates, isolates)
Supply of starting materials and standardized ingredient formats (full/broad spectrum oils, water-soluble powders, distillates, isolates) available in conventional or delivery-optimized formulations for manufacturing.
VESIsorb
An exclusively licensed drug delivery technology that dramatically improves the bioavailability and absorption of poorly absorbed ingredients like cannabis oil by utilizing a self-assembling colloidal system.
Services
Project-based formulation development and optimization of lipophilic active and terpene products across multiple dosage forms and matrices for consumer, medical and animal applications.
Licensing and transfer of patented colloidal delivery technologies and associated formulation know-how to brand partners and manufacturers, including implementation support for private-label products.
Coordination of independent laboratory testing, stability studies and QA/QC processes to support product safety, labeling and regulatory requirements.
Project-based formulation development and optimization of lipophilic active and terpene products across multiple dosage forms and matrices for consumer, medical and animal applications.
Licensing and transfer of patented colloidal delivery technologies and associated formulation know-how to brand partners and manufacturers, including implementation support for private-label products.
Coordination of independent laboratory testing, stability studies and QA/QC processes to support product safety, labeling and regulatory requirements.
Expertise Areas
- Drug delivery formulation
- Pharmacokinetics and clinical PK studies
- Custom product formulation and dosage-form development
- Analytical chemistry and third-party testing coordination
Key Technologies
- Colloidal droplet delivery systems
- Self-emulsifying drug delivery systems (SEDDS/SMEDDS)
- Micelle and micro-emulsion technologies
- Dynamic light scattering (particle sizing)
News & Updates
Peer-reviewed double-blind, crossover PK study demonstrating superior Cmax, AUC and Tmax for a colloidal lipid-based formulation of broad spectrum hemp extract versus the same extract in MCT oil.
Published human study reporting increased Cmax and AUC and reduced Tmax for a beta-caryophyllene formulation using a colloidal delivery approach.
Announcements of strategic partnerships enabling distribution of delivery-system-formulated products into additional retail and regional markets, including expansion to European distribution channels.
Overview of a colloidal droplet delivery platform, its clinical evidence base, and applications across nutraceuticals, pharmaceuticals, cosmetics and medical devices, including partner case studies and commercialization examples.
Site states more than 40 granted and pending patents, 25+ market-ready products and multiple clinical studies underway.
The delivery-platform overview cites over 30 years of development and published pharmacokinetic evidence and notes commercialization of delivery-system formulations across global markets.
Peer-reviewed double-blind, crossover PK study demonstrating superior Cmax, AUC and Tmax for a colloidal lipid-based formulation of broad spectrum hemp extract versus the same extract in MCT oil.
Published human study reporting increased Cmax and AUC and reduced Tmax for a beta-caryophyllene formulation using a colloidal delivery approach.
Announcements of strategic partnerships enabling distribution of delivery-system-formulated products into additional retail and regional markets, including expansion to European distribution channels.
Overview of a colloidal droplet delivery platform, its clinical evidence base, and applications across nutraceuticals, pharmaceuticals, cosmetics and medical devices, including partner case studies and commercialization examples.
Site states more than 40 granted and pending patents, 25+ market-ready products and multiple clinical studies underway.
The delivery-platform overview cites over 30 years of development and published pharmacokinetic evidence and notes commercialization of delivery-system formulations across global markets.